Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Heimfeld

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Stem Cells (Dayton, Ohio)|September 30, 2000
Results of retroviral and adenoviral approaches to cancer gene therapyL H Yin, S Q Fu, T Nanakorn, et al.
Journal of Hematotherapy|December 1, 1995
Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantationM H Purdy, C J Hogan, L Hami, et al.
Blood|June 1, 1996
BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patientsC M Verfaillie, R Bhatia, W Miller, et al.
Leukemia & Lymphoma|February 26, 1999
Hematopoietic retroviral gene marking in patients with follicular non-Hodgkin's lymphomaC R Bachier, R E Giles, D Ellerson, et al.
Leukemia|March 18, 2005
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantationF Baron, M B Maris, B E Storer, et al.
Blood|November 24, 2001
CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantationJ M Zaucha, T Gooley, W I Bensinger, et al.
Blood|December 10, 1999
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantationL A Holmberg, M Boeckh, H Hooper, et al.
Bone Marrow Transplantation|August 2, 2016
Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?S Gallo, A E Woolfrey, L M Burroughs, et al.
British Journal of Haematology|February 24, 2005
Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioningJ P Panse, S Heimfeld, K A Guthrie, et al.
Leukemia|July 4, 2008
Decreased IRF8 expression found in aging hematopoietic progenitor/stem cellsD L Stirewalt, Y E Choi, N E Sharpless, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Stem Cells (Dayton, Ohio)|September 30, 2000
Results of retroviral and adenoviral approaches to cancer gene therapyL H Yin, S Q Fu, T Nanakorn, et al.
Journal of Hematotherapy|December 1, 1995
Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantationM H Purdy, C J Hogan, L Hami, et al.
Blood|June 1, 1996
BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patientsC M Verfaillie, R Bhatia, W Miller, et al.
Leukemia & Lymphoma|February 26, 1999
Hematopoietic retroviral gene marking in patients with follicular non-Hodgkin's lymphomaC R Bachier, R E Giles, D Ellerson, et al.
Leukemia|March 18, 2005
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantationF Baron, M B Maris, B E Storer, et al.
Blood|November 24, 2001
CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantationJ M Zaucha, T Gooley, W I Bensinger, et al.
Blood|December 10, 1999
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantationL A Holmberg, M Boeckh, H Hooper, et al.
Bone Marrow Transplantation|August 2, 2016
Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?S Gallo, A E Woolfrey, L M Burroughs, et al.
British Journal of Haematology|February 24, 2005
Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioningJ P Panse, S Heimfeld, K A Guthrie, et al.
Leukemia|July 4, 2008
Decreased IRF8 expression found in aging hematopoietic progenitor/stem cellsD L Stirewalt, Y E Choi, N E Sharpless, et al.
Pageof 8